Innovative Drug R&D and Industrial Transformation Platform
This platform covers preclinical research and industrial transformation of innovative drugs such as genetically engineered recombinant proteases, human and humanized antibodies for new targets, recombinant major allergen desensitization drugs, modified long-acting protein, and peptides medicines.
Precision Medicine Companion Diagnostics Product R&D and Transformation Platform
This platform is dedicated to the early prevention and diagnosis of diseases, predicting drug efficacy, selecting specific drug responders, and determining drug dosage. It aims to develop personalized treatment plans based on the concept of precision medicine.
Analytical Methodology Research and Validation Platform
This platform focuses on professional and standardized research and validation of quality analysis methodologies, stability investigations, and comprehensive control of drug quality at different stages of preclinical research.
Pharmacology and Safety Evaluation Platform
This platform is a technologically mature platform for high-quality animal model-based pharmacology and non-GLP safety evaluation studies. It supports the efficacy screening, safety evaluation, and investigation of drug mechanisms at various stages of innovative drug discovery and development.
Comprehensive Quality Assurance Management Platform
Quality originates from design, and quality management is integrated into every stage of the new drug development process. This platform establishes a quality management system that covers the entire lifecycle of drug preclinical research and development.
Jiangsu Engineering Research Center for Precision Biomedicines
This center is an innovative platform focusing on all-round research and industrialization of "precise biological innovative drugs" and "precision clinical diagnostic products."